Structural insights on identification of potential lead compounds targeting WbpP in Vibrio vulnificus through structure-based approaches

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Receptor and Signal Transduction Research

• Publication date

  2016-01-21

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.3109/10799893.2015.1132237PMID 26795501
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural insights of JAK2 inhibitors: pharmacophore modeling and ligand-based 3D-QSAR studies of pyrido-indole derivatives

  2015influential reference
• Molecular insights of benzodipyrazole as CDK2 inhibitors: combined molecular docking, molecular dynamics, and 3D QSAR studies

  2015influential reference
• Homology modeling and virtual screening of ubiquitin conjugation enzyme E2A for designing a novel selective antagonist against cancer

  2015cited by this paper
• Molecular modeling studies and comparative analysis on structurally similar HTLV and HIV protease using HIV-PR inhibitors

  2014cited by this paper
• Development of 3D-pharmacophore model followed by successive virtual screening, molecular docking and ADME studies for the design of potent CCR2 antagonists for inflammation-driven diseases

  2013cited by this paper
• Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase

  2013cited by this paper
• Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)

  2013cited by this paper
• Towards the virtual screening of BIK inhibitors with the homology-modeled protein structure

  2013cited by this paper
• Docking and molecular dynamics simulations studies of human protein kinase catalytic subunit alpha with antagonist

  2012cited by this paper
• In silico structural and functional analysis of the human TOPK protein by structure modeling and molecular dynamics studies

  2012cited by this paper
• Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy

  2011cited by this paper
• Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM–GBSA calculation

  2011cited by this paper
• Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation.

  2011cited by this paper
• Docking Studies of Adenosine Analogues with NS5 Methyltransferase of Yellow Fever Virus

  2011cited by this paper
• Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.

  2010cited by this paper
• Vibrio vulnificus: Disease and Pathogenesis

  2009cited by this paper
• Vibrio vulnificus Biotype 2 Serovar E gne but Not galE Is Essential for Lipopolysaccharide Biosynthesis and Virulence

  2008cited by this paper
• Docking mode of delvardine and its analogues into the p66 domain of HIV-1 reverse transcriptase: screening using molecular mechanics-generalized born/surface area and absorption, distribution, metabolism and excretion properties

  2007cited by this paper
• Phospholipase A as a potent virulence factor of Vibrio vulnificus.

  2007cited by this paper
• Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice.

  2007cited by this paper
• Novel procedure for modeling ligand/receptor induced fit effects.

  2006cited by this paper
• Identification of the Vibrio vulnificus wbpP Gene and Evaluation of Its Role in Virulence

  2006cited by this paper
• The PMDB Protein Model Database

  2005cited by this paper
• Molecular Pathogenesis of Vibrio vulnificus.

  2005cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

  2004cited by this paper
• ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins

  2003cited by this paper
• Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy.

  2003cited by this paper
• SWISS-MODEL: an automated protein homology-modeling server

  2003cited by this paper
• Comparative genome analysis of Vibrio vulnificus, a marine pathogen.

  2003cited by this paper
• THE α1b-ADRENERGIC RECEPTOR SUBTYPE: MOLECULAR PROPERTIES AND PHYSIOLOGICAL IMPLICATIONS

  2002cited by this paper
• ESyPred3D: Prediction of proteins 3D structures

  2002cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Expression, Purification, and Biochemical Characterization of WbpP, a New UDP-GlcNAc C4 Epimerase from Pseudomonas aeruginosa Serotype O6*

  2000cited by this paper
• Pathogenesis of Vibrio vulnificus.

  1999cited by this paper
• An Epimerase Gene Essential for Capsule Synthesis in Vibrio vulnificus

  1998cited by this paper
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

  1997cited by this paper
• Thirty years of environmental health research--and growing.

  1996cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus

  1992cited by this paper

• Anti-vibriosis bioactive molecules from Arctic Penicillium sp. Z2230

  2023cites this paper
• Racemases and epimerases operating through a 1,1-proton transfer mechanism: reactivity, mechanism and inhibition

  2021cites this paper
• Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery–a structure-based approach

  2017cites this paper
• Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy

  2017cites this paper